Amarin Loses Bid for Vascepa 5-Year Market Exclusivity
moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]
AMRN
Amarin to Report Fourth Quarter and Year-End 2013 Results and Host Conference Call on February 27, 2014
[GlobeNewswire] – BEDMINSTER, N.J. and DUBLIN, Ireland — Amarin Corporation plc , a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced … moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]
4:01 pm Amarin confirms FDA Award of three-year exclusivity for Vascepa Capsules
moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]
4:01 pm Amarin confirms FDA Award of three-year exclusivity for Vascepa Capsules
moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]
Amarin Given 3-Year Exclusivity for Vascepa
moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]
4:01 pm Amarin confirms FDA Award of three-year exclusivity for Vascepa Capsules
moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]
AMARIN CORP PLCUK Files SEC form 8-K, Other Events
moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]
Amarin Announces FDA Award of Three-Year Exclusivity for Vascepa(R) (icosapent ethyl) Capsules
[GlobeNewswire] – BEDMINSTER, N.J. and DUBLIN, Ireland — Amarin Corporation plc , a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced … moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]
Amarin Corporation Plc’s Rocky Road
moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]
Amarin Announces Approval of Supplemental New Drug Application for Chemport as Additional Vascepa(R) Active Pharmaceutical Ingredient Supplier
[at noodls] – BEDMINSTER, N.J. and DUBLIN, Ireland, April 18, 2013 (GLOBE NEWSWIRE) — Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics … moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]
